On March 6, 2018 Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, reported that Isaac Ciechanover, M.D., the Company’s President and Chief Executive Officer, will present at the Cowen and Company 38th Annual Health Care Conference on Tuesday, March 13, 2018 at 8:00 a.m. EDT (Press release, Atara Biotherapeutics, MAR 6, 2018, http://investors.atarabio.com/news-releases/news-release-details/atara-biotherapeutics-present-cowen-and-company-38th-annual [SID1234524435]). The conference will be held at the Boston Marriott Copley Place Hotel in Boston, MA.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast of the presentation will be available by visiting the Investors section of the Atara website at www.atarabio.com. An archived replay of the webcast will be available on the Company’s website for 14 days following the presentation.

On March 6, 2018 Aptose Biosciences Inc. ("Aptose" or the "Company") (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, reported that William G. Rice, Ph.D., Chairman, President and Chief Executive Officer, and Gregory K. Chow, Senior Vice President and Chief Financial Officer, will participate at the upcoming conferences (Press release, Aptose Biosciences, MAR 6, 2018, View Source;p=RssLanding&cat=news&id=2336407 [SID1234524433]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen and Company 38th Annual Healthcare Conference
Time: 12:00 p.m. EDT
Date: Monday, March 12, 2018
Location: The Boston Marriott Copley Place, Boston, MA
Live webcast: http://wsw.com/webcast/cowen46/apto/

30th Annual ROTH Conference
Time: 9:30 a.m. PDT
Date: Tuesday, March 13, 2018
Location: The Ritz Carlton, Laguna Niguel, CA
Live webcast: View Source

2018 B. Riley & Co. China Healthcare Investment Partnering Symposium
Time: 11:30 a.m. CST (China Standard Time)
Date: Friday, March 16, 2018
Location: The Intercontinental Hotel, Hangzhou, People’s Republic of China
Live webcast: View Source

Oppenheimer 28th Annual Healthcare Conference
Time: 8:00 a.m. EDT
Date: Wednesday, March 21, 2018
Location: The Westin Grand Central, New York, NY
Live webcast: https://veracast.com/webcasts/opco/healthcare2018/76201109497.cfm

The audio webcasts can also be accessed through the Aptose website at www.aptose.com and will be archived shortly after the live event and available for 90 days.

On March 6, 2018 Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, reported that Bill Enright, President and Chief Executive Officer, will provide a corporate overview at the 30th Annual ROTH Conference and the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium (Press release, Altimmune, MAR 6, 2018, View Source [SID1234524432]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

30th Annual ROTH Conference Presentation Details
Date: Tuesday, March 13
Time: 7:00pm Eastern Time/4:00pm Pacific Time
Location: The Ritz Carlton Orange County, Newport Beach, California – Salon 6

B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium (CHIPS)
Date: Saturday, March 17
Time: 8:30am China Time/7:30pm Eastern Time – Room A
Location: Intercontinental Hotel, Hangzhou, China

On March 6, 2018 TG Therapeutics, Inc. (NASDAQ:TGTX), reported that a conference call will be held on Thursday March 8, 2018 to discuss results for the fourth quarter and year-end 2017, and provide a business outlook for 2018 (Press release, TG Therapeutics, MAR 6, 2018, View Source [SID1234524423]). Michael S. Weiss, Executive Chairman and Chief Executive Officer, will host the call.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

In order to participate in the conference call, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), Conference Title: TG Therapeutics Year-End 2017 Earnings Call. A live webcast of this presentation will be available on the Events page, located within the Investors & Media section, of the Company’s website at www.tgtherapeutics.com. An audio recording of the conference call will also be available for replay at www.tgtherapeutics.com, for a period of 30 days after the call.

TG Therapeutics will announce its financial results for this period in a press release to be issued prior to the call.

On March 6, 2018 Radius Health, Inc. (Nasdaq:RDUS) reported that Jesper Høiland, President and CEO of the Company, will present a corporate update at Cowen’s 38th Annual Health Care Conference on Monday, March 12, 2018 (Press release, Radius, MAR 6, 2018, View Source [SID1234524421]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Information on the presentation is as follows:

Event: Cowen 38th Annual Health Care Conference
Date: Monday, March 12, 2018
Time: 3:30 p.m. EDT
Location: Dartmouth Room, 3rd Floor, Boston Marriott Copley Place, Boston, MA

A live webcast of the presentation will be available by visiting the Investors section of Radius’ website at View Source A replay of the webcast will be archived on Radius’ website for 30 days following the presentation.